New paper: We approached the topic of AI-based decision support systems in medicine from three distinct perspectives: the ethical one, the behavioral one, and the technical one. Our main hypothesis is that the interaction between physicians and AI recommenders needs to consider multiple aspects from all three disciplines. I think it's the first paper that I was co-writing that had no figures whatsoever ;-) - and it's out now in Technology in Society: https://lnkd.in/e2MRyWJ4 Major thanks to Matthias Uhl, Sebastian Krügel, Alexis Fritz, Angelika Kießig, and Jonas Ammeling for this nice collaboration. Also, a major thanks to the Bayerisches Forschungsinstitut für Digitale Transformation (bidt) for funding our project "ReGInA".
Marc Aubreville’s Post
More Relevant Posts
-
How is AI revolutionizing clinical research? 🌐 In this Xtalks Spotlight, Matthew Herod, MS, Director of Enterprise Data Strategy at PPD Clinical Research, part of Thermo Fisher Scientific, dives into the transformative impact of AI and digitized protocols on clinical trials. Discover how these innovations are driving smarter, faster research and shaping the future of the industry: https://buff.ly/3NI4QAd
To view or add a comment, sign in
-
Step into the future of healthcare innovation at the Egnyte Life Sciences Summit on May 8th! 🚀 Delve into cutting-edge discussions on clinical research, data governance, and the power of AI in R&D. Dive deeper into what's in store by checking out our blog now.
To view or add a comment, sign in
-
🌟 Tomorrow! Mattia Delleani from Humanitas Research Hospital, a valued SYNTHEMA consortium partner, will be the keynote speaker at Thursdays With Science, initiative organised by Fraunhofer Portugal AICOS! Topic: "Opportunities and Challenges of Synthetic Data in Healthcare" Dive into how generative AI and synthetic data are revolutionizing personalized medicine, rare diseases research, and clinical trials with groundbreaking innovations like synthetic control arms and secure data sharing. 🩺 Plus, learn more about the transformative work of the SYNTHEMA project! ✨ Don’t miss this session on the future of healthcare innovation. See you there! #horizoneurope #AI #syntheticdata
Mattia Delleani is the keynote speaker for our next Thursdays With Science! Join us for an open session on "Opportunities and Challenges of Synthetic Data in Healthcare". Find out how generative AI and synthetic data are transforming personalized medicine, especially for rare diseases. Mattia will also delve into innovative approaches like synthetic control arms in clinical trials, secure data sharing, and the groundbreaking SYNTHEMA project. Don’t miss this chance to explore the future of healthcare innovation! Spread the word and register at https://lnkd.in/dyH3F9sY. #AIinHealthcare #SyntheticData #PrecisionMedicine #TwS
To view or add a comment, sign in
-
Catch Saama’s Lisa Moneymaker in her recent interview at #EUCROF24, where her keynote "AI Powered Technology – Game Changer for Clinical Research" strongly resonated with many attendees. 🎤 In this insightful video, Lisa explores the pivotal role of #AI and #ML in clinical development, discussing key concepts and their practical applications. She also highlights the diverse perspectives from #EUCROF24, including regulatory insights, innovation, and transformative change. 💻 Watch the full video and learn more about the event here: https://lnkd.in/e8bt2cqG #EUCROF #clinicalresearch #clinicaltrials #clinicaloperations #gcp #bigpharma #dct
What are your thoughts on Artificial Intelligence across the industry……and what reflections do you have on the EUCROF24 Conference……We ask some of the speakers, attendees and exhibitors…… During the EUCROF24 Conference we spoke with Lisa Moneymaker of Saama, who presented the key note “AI powered Technology – Game Changer for Clinical Research”. In this video, Lisa discusses Artificial Intelligence and Machine Learning, how they apply to clinical development, and some of the different concepts. Lisa also spoke about the different perspectives showcased at EUCROF24, from regulatory to innovation and change, and how the event brings thought leaders together. EUCROF25 will take place in Copenhagen from 2-4 February 2025, and will build on the success of our 2024 event. Find out more here: https://lnkd.in/e8bt2cqG Dr. Martine Dehlinger-Kremer, Simon Lee, Martin O'Kane, Sverre Bengtsson, Benedikt Van Nieuwenhove, Alexandre Malouvier, Antonio Torres, Nicole Bohrmann, Fiona Maini, Cristina Florescu Moraid, Alan Yeomans, Nira Garty #EUCROF #clinicalresearch #clinicaltrials #clinicaloperations #gcp #bigpharma #dct #EUCROF25
To view or add a comment, sign in
-
👩🏻⚕️🔬 Dive into the transformative potential of AI as Dr. Shahar Keinan, CEO and co-founder of POLARISqb and other experts from data science, biology, and healthcare converge to drive groundbreaking innovations in patient care. Their expertise and passion are shaping the future of medicine — right before our eyes! 🎬 Watch the #AI&Us web series and get inspired by the collaborative power of interdisciplinary teamwork. Don’t miss out on the revelations that are setting new benchmarks in patient care: | https://bit.ly/4csbOno | #ScalingAI #AIInLifeSciences
To view or add a comment, sign in
-
The confluence of a number of technological innovations that are currently coming to fruition, including #AI and #Quantum which are at the core of our platform, are poised to make seismic changes in the world of #drugdiscovery. If you are interested in finding out more about how those things are changing the world of #pharmaceutical research, this piece from Dataiku is a great place to begin.
👩🏻⚕️🔬 Dive into the transformative potential of AI as Dr. Shahar Keinan, CEO and co-founder of POLARISqb and other experts from data science, biology, and healthcare converge to drive groundbreaking innovations in patient care. Their expertise and passion are shaping the future of medicine — right before our eyes! 🎬 Watch the #AI&Us web series and get inspired by the collaborative power of interdisciplinary teamwork. Don’t miss out on the revelations that are setting new benchmarks in patient care: | https://bit.ly/4csbOno | #ScalingAI #AIInLifeSciences
To view or add a comment, sign in
-
Modern AI architectures will impact every aspect of both the scientific foundations and the delivery of medicine. Deployed with appropriate caution, it could move us dramatically forward towards precise, proactive, and preventive healthcare for all. At Stanford University School of Medicine we are all in on this vision. Come join us and change the world! https://lnkd.in/gm6uu_dx
To view or add a comment, sign in
-
📆 SAVE THE DATE for Science for health – at SQUARE Brussels on 12 November 2024 – the event where biology meets technology! This year's edition will be all about #AI, #Data & #Digitalization, with the two organizing partners, MEDVIA and BioWin - The Health Cluster of Wallonia!💡🧬🦾 We’ll examine how these tools can accelerate #innovation in #DrugDiscovery & Development and #Prevention & #Diagnostics. With world-class speakers, international case studies, and a collaborative round table, we’ll discuss how #AI, #Data & #Digitalization can help revolutionizing the #healthcare of today and tomorrow 🚀 Science for health brings together academics, industry leaders and policymakers to promote out-of-the-box thinking, tackle complex challenges, and spark new research collaborations. Every past edition has been sold out, with over 300 people uniting to form connections in Belgium and beyond. These collaborations help shape the future of healthcare, tackling current challenges and building a brighter future for all! Get inspired and join forces: save the date today! https://lnkd.in/eY7GXtFf
Home
https://scienceforhealth.eu
To view or add a comment, sign in
-
Currently attending the ABPI annual conference, listening to some interesting panel debates on subjects such as the “Hype or Hope of AI in the future of Healthcare” and the “Trials and Tribulations of Implementing the O’Shaughnessy Review”. Consistent messages throughout reiterating the value of Real World Data in supporting the future growth of the life sciences industry. #realworlddata
To view or add a comment, sign in
-
Unlocking AI in Biotech: AI and Big Data at the Danish BIO Annual Meeting! We’re excited to join the upcoming DANISH BIO - DANSK BIOTEK Annual Meeting, where the spotlight will be on the transformative role of AI and Big Data in biotech. 🔬🧬🤖 Our very own Emma Jappe will present key findings from Biobridge Partners’ recent AI readiness assessment among Nordic biotech companies and moderate a roundtable discussion on the state of AI in the Nordics. This is an invaluable opportunity to network with biotech leaders, reconnect with clients and partners, and gain actionable insights into the future of biotech and AI innovation. 🔗 Interested in joining? Register today via the link in the image below! #AIinBiotech #DanishBIO #BigData #LifeSciencesInnovation #Networking
To view or add a comment, sign in